Clarivate Plc [NYSE: CLVT] loss -0.97% on the last trading session, reaching $12.22 price per share at the time. The company report on August 11, 2022 that Clarivate Declares Dividend on Mandatory Convertible Preferred Shares.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Clarivate Plc (NYSE:CLVT; CLVT PR A), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares, payable in cash on September 1, 2022 to shareholders of record at the close of business on August 15, 2022.
Clarivate Plc represents 674.26 million in outstanding shares, while the company has a total market value of $8.64 billion with the latest information. CLVT stock price has been found in the range of $12.04 to $12.38.
If compared to the average trading volume of 5.00M shares, CLVT reached a trading volume of 7043167 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clarivate Plc [CLVT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLVT shares is $16.19 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLVT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Clarivate Plc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 13, 2022. While these analysts kept the previous recommendation, Citigroup dropped their target price from $35 to $16. The new note on the price target was released on February 04, 2022, representing the official price target for Clarivate Plc stock. Previously, the target price had yet another raise to $16, while Barclays analysts kept a Equal Weight rating on CLVT stock.
The Average True Range (ATR) for Clarivate Plc is set at 0.57, with the Price to Sales ratio for CLVT stock in the period of the last 12 months amounting to 3.67. The Price to Book ratio for the last quarter was 0.85, with the Price to Cash per share for the same quarter was set at 0.51. Price to Free Cash Flow for CLVT in the course of the last twelve months was 106.50 with Quick ratio for the last quarter at 0.80.
Trading performance analysis for CLVT stock
Clarivate Plc [CLVT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.28. With this latest performance, CLVT shares dropped by -15.14% in over the last four-week period, additionally sinking by -23.62% over the last 6 months – not to mention a drop of -48.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLVT stock in for the last two-week period is set at 35.14, with the RSI for the last a single of trading hit 30.09, and the three-weeks RSI is set at 38.40 for Clarivate Plc [CLVT]. The present Moving Average for the last 50 days of trading for this stock 13.79, while it was recorded at 12.83 for the last single week of trading, and 17.01 for the last 200 days.
Clarivate Plc [CLVT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Clarivate Plc [CLVT] shares currently have an operating margin of +2.39 and a Gross Margin at +37.99. Clarivate Plc’s Net Margin is presently recorded at -14.41.
Return on Equity for this stock declined to -2.58, with Return on Assets sitting at -1.55.
Clarivate Plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 0.80.
Clarivate Plc [CLVT]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLVT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clarivate Plc go to 14.60%.
An analysis of insider ownership at Clarivate Plc [CLVT]
There are presently around $6,900 million, or 98.90% of CLVT stock, in the hands of institutional investors. The top three institutional holders of CLVT stocks are: LEONARD GREEN & PARTNERS, L.P. with ownership of 116,666,507, which is approximately 0% of the company’s market cap and around 1.50% of the total institutional ownership; GENERATION INVESTMENT MANAGEMENT LLP, holding 46,298,600 shares of the stock with an approximate value of $565.77 million in CLVT stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $377.42 million in CLVT stock with ownership of nearly 0.081% of the company’s market capitalization.
Positions in Clarivate Plc stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 139 institutional holders increased their position in Clarivate Plc [NYSE:CLVT] by around 56,318,331 shares. Additionally, 150 investors decreased positions by around 57,853,732 shares, while 29 investors held positions by with 450,498,331 shares. The mentioned changes placed institutional holdings at 564,670,394 shares, according to the latest SEC report filing. CLVT stock had 37 new institutional investments in for a total of 15,389,669 shares, while 33 institutional investors sold positions of 6,499,490 shares during the same period.